EATG » Women

Women

Single-tablet dolutegravir-based therapy safe, effective for HIV-infected women

A single-tablet dolutegravir-based combination regimen given daily is noninferior to a multi-pill atazanavir-based regimen in previously untreated women with HIV infection, and has a similar safety profile, researchers say. The…

IPM to advance potential rollout of long-acting HIV prevention products for women

IPM receives award of up to $25 million from USAID through PEPFAR to advance potential rollout of long-acting HIV prevention products for women Award advances regulatory and access strategy for…

Medical male circumcision for HIV has benefits for women too

South African women whose most recent sexual partner was circumcised are less likely to have HIV, suggesting that the voluntary medical male circumcision programmes have benefits for women too, according…

In adolescents, oral Truvada and vaginal ring for HIV prevention are safe, acceptable

NIH-funded clinical trials are first of their kind to include younger adolescent girls. A monthly vaginal ring and a daily oral tablet, both containing anti-HIV drugs, were safe and acceptable…

US study of dapivirine ring in lactating women finds little drug gets into breast milk

Results presented at IAS 2017 support additional studies in breastfeeding and pregnant women PARIS, July 24, 2017 –  The antiretroviral (ARV) drug dapivirine that is released from an experimental vaginal…

Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for close to…

IPM to advance innovative HIV prevention technologies for women

IPM receives multi-year award from UK government to advance innovative technologies for women’s HIV prevention and sexual and reproductive health Funding will expedite development, access to new products that would…

HBV while pregnant increases risk for HBV vaccination failure in newborns

Researchers observed a significant association between the presence of higher hepatitis B DNA at 28 to 30 weeks of gestation in pregnant women and immunoprophylaxis failure in newborns. “The risk…

Incidence of invasive cervical cancer may not be affected by HIV status

Human immunodeficiency virus (HIV) infection may not have a contributory effect on the incidence of invasive cervical cancer (ICC) in women as they age, according to a study published in…

Men often control use of women’s HIV prophylactic gel in Zambia

In Zambia, men often control the use of a microbicide gel that is meant to give women autonomy in preventing HIV infection, according to researchers. Use of the vaginal gel,…